732 related articles for article (PubMed ID: 28488122)
1. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM; Vlahovic G
Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunotherapy for malignant gliomas.
Lin Y; Okada H
Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell vaccines.
Yamanaka R; Kajiwara K
Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
[TBL] [Abstract][Full Text] [Related]
6. Cell-Based Immunotherapy of Gliomas.
Everson RG; Antonios JP; Liau LM
Prog Neurol Surg; 2018; 32():90-100. PubMed ID: 29990977
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell immunotherapy for malignant gliomas.
Luptrawan A; Liu G; Yu JS
Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in Gliomas.
Weant MP; Jesús CM; Yerram P
Semin Oncol Nurs; 2018 Dec; 34(5):501-512. PubMed ID: 30396808
[TBL] [Abstract][Full Text] [Related]
9. Vaccine therapies in malignant glioma.
Oh T; Sayegh ET; Fakurnejad S; Oyon D; Lamano JB; DiDomenico JD; Bloch O; Parsa AT
Curr Neurol Neurosci Rep; 2015 Jan; 15(1):508. PubMed ID: 25431096
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
12. Dendritic-cell- and peptide-based vaccination strategies for glioma.
Yamanaka R
Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell vaccines and immunity in glioma patients.
Wheeler CJ; Black KL
Front Biosci; 2005 Sep; 10():2861-81. PubMed ID: 15970541
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell based vaccination strategy: an evolving paradigm.
Filley AC; Dey M
J Neurooncol; 2017 Jun; 133(2):223-235. PubMed ID: 28434112
[TBL] [Abstract][Full Text] [Related]
15. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based immunotherapy of malignant gliomas.
Parajuli P; Sloan AE
Cancer Invest; 2004; 22(3):405-16. PubMed ID: 15493362
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.
Prins RM; Wang X; Soto H; Young E; Lisiero DN; Fong B; Everson R; Yong WH; Lai A; Li G; Cloughesy TF; Liau LM
J Immunother; 2013 Feb; 36(2):152-7. PubMed ID: 23377664
[TBL] [Abstract][Full Text] [Related]
19. Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas.
Leplina OY; Stupak VV; Kozlov YP; Pendyurin IV; Nikonov SD; Tikhonova MA; Sycheva NV; Ostanin AA; Chernykh ER
Bull Exp Biol Med; 2007 Apr; 143(4):528-34. PubMed ID: 18214316
[TBL] [Abstract][Full Text] [Related]
20. Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.
Zhang Q; Liu F
Cell Death Dis; 2020 Jun; 11(6):485. PubMed ID: 32587256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
